COMPANY
OsteoCentric Technologies
Timeline
- FDA FDA 510(k) clearance: OsteoCentric Navigated Instruments System — K250520, Oct 27, 2025. Applicant at approval: Osteocentric Technologies, Inc. source ↗
- FDA FDA 510(k) clearance: OsteoCentric® UnifiMI® TCS Plating System — K251913, Aug 16, 2025. Applicant at approval: OsteoCentric Technologies. source ↗
- FDA FDA 510(k) clearance: The OsteoCentric Bone Plate and Screw System — K250494, Mar 18, 2025. Applicant at approval: OsteoCentric Technologies. source ↗
FDA records (last 2 years)
- FDA 510(k) clearance: OsteoCentric Navigated Instruments System — K250520, Oct 27, 2025. Applicant at approval: Osteocentric Technologies, Inc. source ↗
- FDA 510(k) clearance: OsteoCentric® UnifiMI® TCS Plating System — K251913, Aug 16, 2025. Applicant at approval: OsteoCentric Technologies. source ↗
- FDA 510(k) clearance: The OsteoCentric Bone Plate and Screw System — K250494, Mar 18, 2025. Applicant at approval: OsteoCentric Technologies. source ↗
NIH awards 3
- NIH award 5R44AR079300-02 FY2023: $210,522 awarded for that fiscal year; activity R44 (SBIR); PI FAUTH, ANDREW RAY; recipient as written: OSTEOCENTRIC TECHNOLOGIES, INC., Austin, TX. Optimization of a Novel Thread Ge source ↗
- NIH award 1R44AR079300-01A1 FY2021: $1,104,366 awarded for that fiscal year; activity R44 (SBIR); PI FAUTH, ANDREW RAY; recipient as written: OSTEOCENTRIC TECHNOLOGIES, INC., Austin, TX. Optimization of a Novel Threa source ↗
- NIH award 1R43AR073096-01A1 FY2018: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI FAUTH, ANDREW RAY; recipient as written: OSTEOCENTRIC TECHNOLOGIES, INC., Austin, TX. Optimization of a Novel Thread source ↗
Connect
See your connections at OsteoCentric Technologies on LinkedIn (search by name, results not checked)